HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  McKinnon, Lyle R ^a,b   Nagelkerke, Nico J ^c,d,e   Kaul, Rupert ^a,b   Shaw, Souradet Y ^c   Capina, Rupert ^f   Luo, Ma ^c,f   Kariri, Anthony ^b   Apidi, Winnie ^c   Kimani, Makobu ^b   Wachihi, Charles ^b   Jaoko, Walter ^b,g   Anzala, A Omu ^b,g   Kimani, Joshua ^b,c   Ball, T Blake ^b,c,h   Plummer, Francis A ^b,c,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF MANITOBA   (Canada)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g Kenyan AIDS Vaccine Initiative   (Kenya)

^h PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLADISTICS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ETHNICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KENYA; KENYAN; MAJOR CLINICAL STUDY; PHYLOGENY; PREDICTION; PROSPECTIVE STUDY; PROSTITUTION; VIRUS LOAD;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANTIGENS, CD4; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; FEMALE; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; KENYA; PHYLOGENY; SEX WORKERS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84869832951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049797     Document Type: Article

References (21)

1. Fauci AS, (2007) Pathogenesis of HIV disease: opportunities for new prevention interventions. Clin Infect Dis 45Suppl 4: S206-212.
2. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM, (2008) The challenge of HIV-1 subtype diversity. N Engl J Med 358: 1590-1602.
3. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, et al. (2008) Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455: 661-664.
4. Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, et al. (1999) Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 73: 4393-4403.
5. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, et al. (1999) Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68-73.
6. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, et al. (2007) HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195: 1177-1180.
7. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, et al. (2008) Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 197: 707-713.
8. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, et al. (2006) Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 42: 843-852.
9. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, et al. (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185: 1244-1250.
10. Kuritzkes DR, (2008) HIV-1 subtype as a determinant of disease progression. J Infect Dis 197: 638-639.
11. Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J, et al. (2007) Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 45: 28-33.
12. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR, (1997) Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185: 621-628.
13. Peters HO, Mendoza MG, Capina RE, Luo M, Mao X, et al. (2008) An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort. J Virol 82: 1980-1992.
14. Goulder PJ, Watkins DI, (2008) Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8: 619-630.
15. Lipsitz SR, Ibrahim J, Molenberghs G, (2000) Using a Box-Cox transformation in the analysis of longitudinal data with incomplete responses. Journal of the Royal Statistical Society Series C (Applied Statistics) 49: 287-296.
16. Yang H, Wu H, Hancock G, Clutton G, Sande N,et al. The antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ cell decline in HIV-1 infection. J Infect Dis.
17. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10: 282-289.
18. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, et al. (2006) Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80: 3617-3623.
19. Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, et al. (2009) HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. Aids 23: 2479-2484.
20. Muller-Trutwin MC, Chaix ML, Letourneur F, Begaud E, Beaumont D, et al. (1999) Increase of HIV-1 subtype A in Central African Republic. J Acquir Immune Defic Syndr 21: 164-171.
21. Margolis L, Shattock R, (2006) Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat Rev Microbiol 4: 312-317.